Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydrochlorothiazide.
Acebutolol
Hydrochlorothiazide may increase the hypotensive activities of Acebutolol.
Aceclofenac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Aceclofenac.
Advertisement
Acemetacin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Acemetacin.
Acetohexamide
The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Hydrochlorothiazide.
Acetyl salicylate
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Acetylsalicylic acid.
Advertisement
Acetyldigitoxin
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Acetyldigitoxin.
Aclidinium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Aclidinium.
Adapalene
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Adapalene.
Advertisement
Albuterol
Salbutamol may increase the hypokalemic activities of Hydrochlorothiazide.
Alclometasone
Alclometasone may increase the hypokalemic activities of Hydrochlorothiazide.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrochlorothiazide.
Aldosterone
Aldosterone may increase the hypokalemic activities of Hydrochlorothiazide.
Alfacalcidol
The risk or severity of hyperkalemia can be increased when Alfacalcidol is combined with Hydrochlorothiazide.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Hydrochlorothiazide.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Hydrochlorothiazide.
Aliskiren
Hydrochlorothiazide may increase the hypotensive activities of Aliskiren.
Allopurinol
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Hydrochlorothiazide.
Alminoprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Alminoprofen.
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydrochlorothiazide.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Hydrochlorothiazide.
Alprenolol
Alprenolol may increase the hypotensive activities of Hydrochlorothiazide.
Ambrisentan
Hydrochlorothiazide may increase the hypotensive activities of Ambrisentan.
Amcinonide
Amcinonide may increase the hypokalemic activities of Hydrochlorothiazide.
Amifostine
Hydrochlorothiazide may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Hydrochlorothiazide may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Hydrochlorothiazide.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Hydrochlorothiazide.
Amlodipine
Amlodipine may increase the hypotensive activities of Hydrochlorothiazide.
Amobarbital
Amobarbital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Amphetamine
Amphetamine may increase the hypotensive activities of Hydrochlorothiazide.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydrochlorothiazide.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydrochlorothiazide.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Amyl Nitrite.
Androstenedione
Androstenedione may increase the hypokalemic activities of Hydrochlorothiazide.
Antipyrine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Antipyrine.
Apazone
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Azapropazone.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydrochlorothiazide.
Apraclonidine
The risk or severity of adverse effects can be increased when Apraclonidine is combined with Hydrochlorothiazide.
Apremilast
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Apremilast.
Arbutamine
Arbutamine may increase the hypokalemic activities of Hydrochlorothiazide.
Arformoterol
Arformoterol may increase the hypokalemic activities of Hydrochlorothiazide.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Hydrochlorothiazide.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydrochlorothiazide.
Aspirin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Acetylsalicylic acid.
Atenolol
Atenolol may increase the hypotensive activities of Hydrochlorothiazide.
Atracurium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Atracurium.
Atracurium Besylate
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Atracurium besylate.
Atropine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Atropine.
Avanafil
Avanafil may increase the antihypertensive activities of Hydrochlorothiazide.
Azelastine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Azelastine.
Azilsartan
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Azilsartan medoxomil.
Balsalazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Balsalazide.
Bambuterol
Bambuterol may increase the hypokalemic activities of Hydrochlorothiazide.
Barbexaclone
Barbexaclone may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Barbital
Barbital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Beclomethasone Dipropionate
Beclomethasone dipropionate may increase the hypokalemic activities of Hydrochlorothiazide.
Benactyzine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Benactyzine.
Benazepril
Hydrochlorothiazide may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Hydrochlorothiazide.
Benztropine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Benzatropine.
Benzydamine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Benzydamine.
Bepridil
Hydrochlorothiazide may increase the hypotensive activities of Bepridil.
Betamethasone
Betamethasone may increase the hypokalemic activities of Hydrochlorothiazide.
Betaxolol
Betaxolol may increase the hypotensive activities of Hydrochlorothiazide.
Bethanidine
Bethanidine may increase the hypotensive activities of Hydrochlorothiazide.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Hydrochlorothiazide.
Biperiden
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Biperiden.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Hydrochlorothiazide.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydrochlorothiazide.
Bosentan
Bosentan may increase the hypotensive activities of Hydrochlorothiazide.
Bretylium
Hydrochlorothiazide may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Hydrochlorothiazide.
Bromfenac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Bromfenac.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Hydrochlorothiazide.
Budesonide
Budesonide may increase the hypokalemic activities of Hydrochlorothiazide.
Bufexamac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Bufexamac.
Bumetanide
The risk or severity of adverse effects can be increased when Bumetanide is combined with Hydrochlorothiazide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydrochlorothiazide.
Bupranolol
Hydrochlorothiazide may increase the hypotensive activities of Bupranolol.
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Hydrochlorothiazide.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Hydrochlorothiazide.
Butylscopolamine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Butylscopolamine.
Cafedrine
Hydrochlorothiazide may increase the hypotensive activities of Cafedrine.
Calcifediol
The risk or severity of hyperkalemia can be increased when Calcidiol is combined with Hydrochlorothiazide.
Calcifediol Anhydrous
The risk or severity of hyperkalemia can be increased when Calcidiol is combined with Hydrochlorothiazide.
Calcipotriene
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Hydrochlorothiazide.
Calcitriol
The risk or severity of hyperkalemia can be increased when Calcitriol is combined with Hydrochlorothiazide.
Calcium Acetate
Hydrochlorothiazide may decrease the excretion rate of Calcium Acetate which could result in a higher serum level.
Calcium Chloride
Hydrochlorothiazide may decrease the excretion rate of Calcium Chloride which could result in a higher serum level.
Calcium Chloride Anhydrous
Hydrochlorothiazide may decrease the excretion rate of Calcium Chloride which could result in a higher serum level.
Calcium Citrate
Hydrochlorothiazide may decrease the excretion rate of Calcium Citrate which could result in a higher serum level.
Calcium Glubionate
Hydrochlorothiazide may decrease the excretion rate of Calcium glubionate which could result in a higher serum level.
Calcium gluceptate
Hydrochlorothiazide may decrease the excretion rate of Calcium Gluceptate which could result in a higher serum level.
Calcium Gluconate
Hydrochlorothiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level.
Calcium Lactate
Hydrochlorothiazide may decrease the excretion rate of Calcium lactate which could result in a higher serum level.
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydrochlorothiazide.
Canagliflozin Anhydrous
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydrochlorothiazide.
Candesartan
Hydrochlorothiazide may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Hydrochlorothiazide.
Captopril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Captopril.
Carbamazepine
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Carbamazepine.
Carprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Carprofen.
Carteolol
Carteolol may increase the hypotensive activities of Hydrochlorothiazide.
Carvedilol
Hydrochlorothiazide may increase the hypotensive activities of Carvedilol.
Casein Allergenic Extract
Hydrochlorothiazide may decrease the excretion rate of Casein which could result in a higher serum level.
Celecoxib
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Celecoxib.
Celiprolol
Celiprolol may increase the hypokalemic activities of Hydrochlorothiazide.
Chloroquine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Chloroquine.
Chlorothiazide
Chlorothiazide may increase the hypotensive activities of Hydrochlorothiazide.
Chlorphenoxamine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Chlorphenoxamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Hydrochlorothiazide.
Chlorpropamide
The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Hydrochlorothiazide.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Hydrochlorothiazide.
Cholecalciferol
The risk or severity of hyperkalemia can be increased when Cholecalciferol is combined with Hydrochlorothiazide.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Hydrochlorothiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Ciclesonide
Ciclesonide may increase the hypokalemic activities of Hydrochlorothiazide.
Cicletanine
Hydrochlorothiazide may increase the hypotensive activities of Cicletanine.
Cilazapril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Cilazapril.
Citalopram
Citalopram may increase the hyponatremic activities of Hydrochlorothiazide.
Clenbuterol
Clenbuterol may increase the hypokalemic activities of Hydrochlorothiazide.
Clevidipine
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Clevidipine.
Clobetasol
Clobetasol may increase the hypokalemic activities of Hydrochlorothiazide.
Clobetasol Propionate
Clobetasol propionate may increase the hypokalemic activities of Hydrochlorothiazide.
Clobetasone
Clobetasone may increase the hypokalemic activities of Hydrochlorothiazide.
Clocortolone
Clocortolone may increase the hypokalemic activities of Hydrochlorothiazide.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Hydrochlorothiazide.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Hydrochlorothiazide.
Clonidine
Clonidine may increase the hypotensive activities of Hydrochlorothiazide.
Clonixin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Clonixin.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Hydrochlorothiazide.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Hydrochlorothiazide.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Hydrochlorothiazide.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Hydrochlorothiazide.
Colesevelam
Colesevelam can cause a decrease in the absorption of Hydrochlorothiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Hydrochlorothiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Hydrochlorothiazide.
Cortisone Acetate
Cortisone acetate may increase the hypokalemic activities of Hydrochlorothiazide.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Hydrochlorothiazide.
Curcumin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Curcumin.
Cyclopenthiazide
Hydrochlorothiazide may increase the hypotensive activities of Cyclopenthiazide.
Cyclopentolate
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Cyclopentolate.
Cyclophosphamide
The risk or severity of severe leukopenia can be increased when Hydrochlorothiazide is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of severe leukopenia can be increased when Hydrochlorothiazide is combined with Cyclophosphamide.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Hydrochlorothiazide.
Dapagliflozin
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Dapagliflozin.
Darifenacin
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Darifenacin.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Hydrochlorothiazide.
Deflazacort
Deflazacort may increase the hypokalemic activities of Hydrochlorothiazide.
Deserpidine
Hydrochlorothiazide may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Hydrochlorothiazide.
Deslanoside
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Deslanoside.
Desloratadine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Desloratadine.
Desonide
Desonide may increase the hypokalemic activities of Hydrochlorothiazide.
Desoximetasone
Desoximetasone may increase the hypokalemic activities of Hydrochlorothiazide.
Desoxycorticosterone acetate
Desoxycorticosterone acetate may increase the hypokalemic activities of Hydrochlorothiazide.
Desoxycorticosterone Pivalate
Desoxycorticosterone Pivalate may increase the hypokalemic activities of Hydrochlorothiazide.
Desvenlafaxine
Desvenlafaxine may increase the hyponatremic activities of Hydrochlorothiazide.
Dexamethasone
Dexamethasone may increase the hypokalemic activities of Hydrochlorothiazide.
Dexetimide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Dexetimide.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Hydrochlorothiazide.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Hydrochlorothiazide.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Hydrochlorothiazide.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Hydrochlorothiazide.
Diazoxide
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Diazoxide.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Diclofenamide.
Diclofenac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Diclofenac.
Dicyclomine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Dicyclomine.
Diflorasone
Diflorasone may increase the hypokalemic activities of Hydrochlorothiazide.
Diflucortolone
Difluocortolone may increase the hypokalemic activities of Hydrochlorothiazide.
Diflunisal
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Diflunisal.
Difluprednate
Difluprednate may increase the hypokalemic activities of Hydrochlorothiazide.
Digitoxin
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digitoxin.
Digoxin
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Hydrochlorothiazide.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Hydrochlorothiazide.
Dihydrotachysterol
The risk or severity of hyperkalemia can be increased when Dihydrotachysterol is combined with Hydrochlorothiazide.
Diltiazem
Diltiazem may increase the hypotensive activities of Hydrochlorothiazide.
Dinutuximab
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Dinutuximab.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Hydrochlorothiazide.
Dipivefrin
Dipivefrin may increase the hypokalemic activities of Hydrochlorothiazide.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Hydrochlorothiazide.
Dipyrone
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Metamizole.
Dobutamine
Dobutamine may increase the hypokalemic activities of Hydrochlorothiazide.
Dofetilide
Hydrochlorothiazide may increase the QTc-prolonging activities of Dofetilide.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Hydrochlorothiazide.
Doxazosin
Doxazosin may increase the hypotensive activities of Hydrochlorothiazide.
Doxercalciferol
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Hydrochlorothiazide.
Droxicam
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Droxicam.
Droxidopa
Droxidopa may increase the hypokalemic activities of Hydrochlorothiazide.
Dulaglutide
The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Hydrochlorothiazide.
Duloxetine
Hydrochlorothiazide may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Hydrochlorothiazide.
Enalapril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Enalapril.
Enalaprilat
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Enalaprilat.
Epinephrine
Epinephrine may increase the hypokalemic activities of Hydrochlorothiazide.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Hydrochlorothiazide.
Epoprostenol
Hydrochlorothiazide may increase the hypotensive activities of Epoprostenol.
Eprosartan
Eprosartan may increase the hypotensive activities of Hydrochlorothiazide.
Ergocalciferol
The risk or severity of hyperkalemia can be increased when Ergocalciferol is combined with Hydrochlorothiazide.
Escitalopram
Escitalopram may increase the hyponatremic activities of Hydrochlorothiazide.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Hydrochlorothiazide.
Estrone
Estrone may increase the hypokalemic activities of Hydrochlorothiazide.
Etanercept
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Etanercept.
Ethacrynate
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Hydrochlorothiazide.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Hydrochlorothiazide.
Ethanol
Ethanol may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Hydrochlorothiazide.
Etodolac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Etodolac.
Etofenamate
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Etofenamate.
Etoricoxib
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Etoricoxib.
Evening primrose oil
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Evening primrose oil.
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with Hydrochlorothiazide.
Felbinac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Felbinac.
Felodipine
Hydrochlorothiazide may increase the hypotensive activities of Felodipine.
Fenbufen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Fenbufen.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Hydrochlorothiazide.
Fenoprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Fenoprofen.
Fenoterol
Fenoterol may increase the hypokalemic activities of Hydrochlorothiazide.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Hydrochlorothiazide.
Ferulic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ferulic acid.
Fesoterodine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Fesoterodine.
Floctafenine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Floctafenine.
Fludrocortisone
Fludrocortisone may increase the hypokalemic activities of Hydrochlorothiazide.
Flumethasone
Flumethasone may increase the hypokalemic activities of Hydrochlorothiazide.
Flunisolide
Flunisolide may increase the hypokalemic activities of Hydrochlorothiazide.
Flunisolide Anhydrous (obsolete)
Flunisolide may increase the hypokalemic activities of Hydrochlorothiazide.
Fluocinolone Acetonide
Fluocinolone Acetonide may increase the hypokalemic activities of Hydrochlorothiazide.
Fluocinonide
Fluocinonide may increase the hypokalemic activities of Hydrochlorothiazide.
Fluocortolone
Fluocortolone may increase the hypokalemic activities of Hydrochlorothiazide.
Fluorometholone
Fluorometholone may increase the hypokalemic activities of Hydrochlorothiazide.
Fluoxetine
Fluoxetine may increase the hyponatremic activities of Hydrochlorothiazide.
FLUPREDNIDENE
Fluprednidene may increase the hypokalemic activities of Hydrochlorothiazide.
Fluprednisolone
Fluprednisolone may increase the hypokalemic activities of Hydrochlorothiazide.
Flurandrenolide
Flurandrenolide may increase the hypokalemic activities of Hydrochlorothiazide.
Flurbiprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Flurbiprofen.
Fluticasone Furoate
Fluticasone furoate may increase the hypokalemic activities of Hydrochlorothiazide.
Fluticasone propionate
Fluticasone propionate may increase the hypokalemic activities of Hydrochlorothiazide.
Fluvoxamine
Fluvoxamine may increase the hyponatremic activities of Hydrochlorothiazide.
Formestane
Formestane may increase the hypokalemic activities of Hydrochlorothiazide.
Formoterol
Formoterol may increase the hypokalemic activities of Hydrochlorothiazide.
Fosinopril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Fosinopril.
Furazolidone
Furazolidone may increase the hypotensive activities of Hydrochlorothiazide.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Hydrochlorothiazide.
Gallamine Triethiodide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Gallamine Triethiodide.
Glibornuride
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hydrochlorothiazide.
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydrochlorothiazide.
Glimepiride
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydrochlorothiazide.
Glipizide
The therapeutic efficacy of Glipizide can be decreased when used in combination with Hydrochlorothiazide.
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydrochlorothiazide.
Glyburide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydrochlorothiazide.
Glycopyrronium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Glycopyrronium.
Guanabenz
Guanabenz may increase the hypotensive activities of Hydrochlorothiazide.
Guanadrel
Guanadrel may increase the hypotensive activities of Hydrochlorothiazide.
Guanethidine
Hydrochlorothiazide may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Hydrochlorothiazide.
Halcinonide
Halcinonide may increase the hypokalemic activities of Hydrochlorothiazide.
Halobetasol
Ulobetasol may increase the hypokalemic activities of Hydrochlorothiazide.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Hydrochlorothiazide.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Hydrochlorothiazide.
Hexobarbital
Hexobarbital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Homatropine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Homatropine.
Hydralazine
Hydralazine may increase the hypotensive activities of Hydrochlorothiazide.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Hydrochlorothiazide.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Hydrochlorothiazide.
Hydrocortisone
Hydrocortisone may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Hydrochlorothiazide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Hydrochlorothiazide.
Hyoscyamine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Hyoscyamine.
Ibuprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ibuprofen.
Icatibant
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Icatibant.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Hydrochlorothiazide.
Imidapril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Hydrochlorothiazide.
Indacaterol
Indacaterol may increase the hypokalemic activities of Hydrochlorothiazide.
Indapamide
Indapamide may increase the hypotensive activities of Hydrochlorothiazide.
Indobufen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Indobufen.
Indomethacin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Indomethacin.
Indoramin
Indoramin may increase the hypotensive activities of Hydrochlorothiazide.
Insulin Detemir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Hydrochlorothiazide.
Insulin Glargine
The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Hydrochlorothiazide.
insulin human, rDNA origin
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Hydrochlorothiazide.
Insulin Lispro
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Hydrochlorothiazide.
Insulin, Aspart Protamine, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Hydrochlorothiazide.
Insulin, Aspart, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Hydrochlorothiazide.
Insulin, Glulisine, Human
The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Hydrochlorothiazide.
Insulin, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Hydrochlorothiazide.
Insulin, Protamine Lispro, Human
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Hydrochlorothiazide.
Insulin, Regular, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Hydrochlorothiazide.
Ipratropium Bromide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Ipratropium bromide.
Ipratropium Bromide Anhydrous
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Ipratropium bromide.
Iproniazid
Iproniazid may increase the hypotensive activities of Hydrochlorothiazide.
Irbesartan
Hydrochlorothiazide may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Hydrochlorothiazide.
Isoetharine
Isoetarine may increase the hypokalemic activities of Hydrochlorothiazide.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Hydrochlorothiazide.
Isoproterenol
Isoprenaline may increase the hypokalemic activities of Hydrochlorothiazide.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Isosorbide Dinitrate is combined with Hydrochlorothiazide.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Hydrochlorothiazide.
Ivabradine
Hydrochlorothiazide may increase the arrhythmogenic activities of Ivabradine.
Kebuzone
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Kebuzone.
Ketanserin
Ketanserin may increase the hypotensive activities of Hydrochlorothiazide.
Ketoprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ketoprofen.
Ketorolac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ketorolac.
Labetalol
Labetalol may increase the hypotensive activities of Hydrochlorothiazide.
Lacidipine
Hydrochlorothiazide may increase the hypotensive activities of Lacidipine.
Latanoprost
Latanoprost may increase the hypotensive activities of Hydrochlorothiazide.
Leflunomide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Leflunomide.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Hydrochlorothiazide.
Levalbuterol
Levosalbutamol may increase the hypokalemic activities of Hydrochlorothiazide.
Levobunolol
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Hydrochlorothiazide.
Levodopa
Hydrochlorothiazide may increase the orthostatic hypotensive activities of Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Hydrochlorothiazide.
Levomilnacipran
Levomilnacipran may increase the hyponatremic activities of Hydrochlorothiazide.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Hydrochlorothiazide.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Hydrochlorothiazide.
Licorice Allergenic Extract
Licorice may increase the hypokalemic activities of Hydrochlorothiazide.
Limonene, (+)-
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with (4R)-limonene.
Linagliptin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Hydrochlorothiazide.
Liraglutide
The therapeutic efficacy of Liraglutide can be decreased when used in combination with Hydrochlorothiazide.
Lisinopril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Lisinopril.
Lithium
Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.
Lithium Cation
Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.
Lofexidine
Hydrochlorothiazide may increase the hypotensive activities of Lofexidine.
Lornoxicam
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Lornoxicam.
Losartan
Losartan may increase the hypotensive activities of Hydrochlorothiazide.
Loteprednol
Loteprednol may increase the hypokalemic activities of Hydrochlorothiazide.
Loxoprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Loxoprofen.
Macitentan
Hydrochlorothiazide may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Magnesium salicylate.
Manidipine
Hydrochlorothiazide may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Hydrochlorothiazide.
Masoprocol
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Masoprocol.
Mecamylamine
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Mecamylamine.
Meclofenamate
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meclofenamic acid.
Meclofenamic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meclofenamic acid.
Medrysone
Medrysone may increase the hypokalemic activities of Hydrochlorothiazide.
Mefenamic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Mefenamic acid.
Meloxicam
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meloxicam.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Hydrochlorothiazide.
Mephobarbital
Methylphenobarbital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Mepirodipine
Hydrochlorothiazide may increase the antihypertensive activities of Barnidipine.
Mesalamine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Mesalazine.
Metaproterenol
Orciprenaline may increase the hypokalemic activities of Hydrochlorothiazide.
Metformin
The therapeutic efficacy of Metformin can be decreased when used in combination with Hydrochlorothiazide.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Hydrochlorothiazide.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Hydrochlorothiazide.
Methantheline
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Methantheline.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Hydrochlorothiazide.
Methixene
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Metixene.
Methohexital
Methohexital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Methscopolamine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Methscopolamine.
Methscopolamine Bromide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Methylscopolamine bromide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Hydrochlorothiazide.
Methyldopa
Methyldopa may increase the hypotensive activities of Hydrochlorothiazide.
METHYLDOPA ANHYDROUS
Methyldopa may increase the hypotensive activities of Hydrochlorothiazide.
Methylene blue
Methylene blue may increase the hypotensive activities of Hydrochlorothiazide.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Hydrochlorothiazide.
Methylprednisolone
Methylprednisolone may increase the hypokalemic activities of Hydrochlorothiazide.
Metipranolol
Hydrochlorothiazide may increase the hypotensive activities of Metipranolol.
Metolazone
Metolazone may increase the hypotensive activities of Hydrochlorothiazide.
Metoprolol
Metoprolol may increase the hypotensive activities of Hydrochlorothiazide.
Metyrosine
Hydrochlorothiazide may increase the hypotensive activities of Metyrosine.
Mibefradil
Hydrochlorothiazide may increase the hypotensive activities of Mibefradil.
Miglitol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Hydrochlorothiazide.
Miglustat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Hydrochlorothiazide.
Milnacipran
Milnacipran may increase the hyponatremic activities of Hydrochlorothiazide.
Minaprine
Minaprine may increase the hypotensive activities of Hydrochlorothiazide.
Minoxidil
Minoxidil may increase the hypotensive activities of Hydrochlorothiazide.
Moclobemide
Moclobemide may increase the hypotensive activities of Hydrochlorothiazide.
Moexipril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Hydrochlorothiazide.
Mometasone
Mometasone may increase the hypokalemic activities of Hydrochlorothiazide.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Hydrochlorothiazide.
Moxonidine
Moxonidine may increase the hypotensive activities of Hydrochlorothiazide.
MYCOPHENOLATE
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Mycophenolic acid.
Mycophenolate Mofetil
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Mycophenolate mofetil.
Mycophenolic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Mycophenolic acid.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Hydrochlorothiazide.
Nabumetone
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nabumetone.
Nadolol
Hydrochlorothiazide may increase the hypotensive activities of Nadolol.
Naftifine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Naftifine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hydrochlorothiazide.
Naproxen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Naproxen.
Nateglinide
The therapeutic efficacy of Nateglinide can be decreased when used in combination with Hydrochlorothiazide.
Nebivolol
Hydrochlorothiazide may increase the hypotensive activities of Nebivolol.
Nefazodone
Nefazodone may increase the hyponatremic activities of Hydrochlorothiazide.
Nepafenac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nepafenac.
Nesiritide
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Hydrochlorothiazide.
Nicardipine
Nicardipine may increase the hypotensive activities of Hydrochlorothiazide.
Nicorandil
Nicorandil may increase the hypotensive activities of Hydrochlorothiazide.
Nifedipine
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Nifedipine.
Niflumic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Niflumic Acid.
Nilvadipine
Hydrochlorothiazide may increase the hypotensive activities of Nilvadipine.
Nimesulide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nimesulide.
Nimodipine
Nimodipine may increase the hypotensive activities of Hydrochlorothiazide.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Hydrochlorothiazide.
Nitrendipine
Hydrochlorothiazide may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Hydrochlorothiazide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Hydrochlorothiazide.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Hydrochlorothiazide.
Norepinephrine
Norepinephrine may increase the hypokalemic activities of Hydrochlorothiazide.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Hydrochlorothiazide.
Obinutuzumab
Hydrochlorothiazide may increase the hypotensive activities of Obinutuzumab.
Octotropine Methylbromide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Anisotropine Methylbromide.
Octylonium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Otilonium.
Oenothera biennis seed extract
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Evening primrose oil.
Olmesartan
Olmesartan may increase the hypotensive activities of Hydrochlorothiazide.
Olodaterol
Olodaterol may increase the hypokalemic activities of Hydrochlorothiazide.
Olopatadine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Olopatadine.
Olsalazine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Olsalazine.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Hydrochlorothiazide.
Orphenadrine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Orphenadrine.
Ouabain
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Ouabain.
Ovine Digoxin Immune Fab
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin Immune Fab (Ovine).
Oxaprozin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxaprozin.
Oxcarbazepine
The risk or severity of hyponatremia can be increased when Hydrochlorothiazide is combined with Oxcarbazepine.
Oxitropium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxitropium.
Oxprenolol
Hydrochlorothiazide may increase the hypotensive activities of Oxprenolol.
Oxybutynin
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxybutynin.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Hydrochlorothiazide.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Hydrochlorothiazide.
Oxyphenbutazone
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxyphenbutazone.
Oxyphenonium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxyphenonium.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Hydrochlorothiazide.
Pancuronium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Pancuronium.
Pancuronium Bromide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Pancuronium.
Papaverine
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Papaverine.
Paramethasone
Paramethasone may increase the hypokalemic activities of Hydrochlorothiazide.
Parecoxib
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Parecoxib.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Hydrochlorothiazide.
Pargyline
Pargyline may increase the hypotensive activities of Hydrochlorothiazide.
Paricalcitol
The risk or severity of hyperkalemia can be increased when Paricalcitol is combined with Hydrochlorothiazide.
Paroxetine
Paroxetine may increase the hyponatremic activities of Hydrochlorothiazide.
Parthenolide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Parthenolide.
Penbutolol
Hydrochlorothiazide may increase the hypotensive activities of Penbutolol.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Hydrochlorothiazide.
Pentobarbital
Pentobarbital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Hydrochlorothiazide.
Perindopril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Hydrochlorothiazide.
Phenformin
The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydrochlorothiazide.
Phenobarbital
Phenobarbital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Phenoxybenzamine
Phenoxybenzamine may increase the hypotensive activities of Hydrochlorothiazide.
Phentolamine
Phentolamine may increase the hypotensive activities of Hydrochlorothiazide.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Hydrochlorothiazide.
Phenylbutazone
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Phenylbutazone.
Phenylpropanolamine
Phenylpropanolamine may increase the hypokalemic activities of Hydrochlorothiazide.
Pimecrolimus
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Pimecrolimus.
Pinacidil
Pinacidil may increase the hypotensive activities of Hydrochlorothiazide.
Pindolol
Pindolol may increase the hypotensive activities of Hydrochlorothiazide.
Pioglitazone
The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Hydrochlorothiazide.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Hydrochlorothiazide.
Pipecuronium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Pipecuronium.
Pirbuterol
Pirbuterol may increase the hypokalemic activities of Hydrochlorothiazide.
Pirenzepine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Pirenzepine.
Pirfenidone
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Pirfenidone.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Hydrochlorothiazide.
Piroxicam
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Piroxicam.
Polythiazide
Hydrochlorothiazide may increase the hypotensive activities of Polythiazide.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Hydrochlorothiazide.
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with Hydrochlorothiazide.
Prasterone
Prasterone may increase the hypokalemic activities of Hydrochlorothiazide.
Prazosin
Prazosin may increase the hypotensive activities of Hydrochlorothiazide.
Prednicarbate
Prednicarbate may increase the hypokalemic activities of Hydrochlorothiazide.
Prednisolone
Prednisolone may increase the hypokalemic activities of Hydrochlorothiazide.
Prednisone
Prednisone may increase the hypokalemic activities of Hydrochlorothiazide.
Pregnenolone
Pregnenolone may increase the hypokalemic activities of Hydrochlorothiazide.
Primidone
Primidone may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Procarbazine
Procarbazine may increase the hypotensive activities of Hydrochlorothiazide.
Procaterol
Procaterol may increase the hypokalemic activities of Hydrochlorothiazide.
Procyclidine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Procyclidine.
Profenamine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Ethopropazine.
Propantheline
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Propantheline.
Propantheline Bromide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Propantheline.
Propiverine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Propiverine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Hydrochlorothiazide.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Hydrochlorothiazide.
Propranolol
Propranolol may increase the hypotensive activities of Hydrochlorothiazide.
Proscillaridin
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Proscillaridin.
Quetiapine
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Quetiapine.
Quinapril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Quinapril.
Quinidine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Quinidine.
Quinine
Quinine may increase the hypotensive activities of Hydrochlorothiazide.
Ramipril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Ramipril.
Rasagiline
Rasagiline may increase the hypotensive activities of Hydrochlorothiazide.
Regular Insulin, Human
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Hydrochlorothiazide.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Hydrochlorothiazide.
Repaglinide
The therapeutic efficacy of Repaglinide can be decreased when used in combination with Hydrochlorothiazide.
Rescinnamine
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Hydrochlorothiazide.
Resveratrol
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Resveratrol.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Hydrochlorothiazide.
Rimexolone
Rimexolone may increase the hypokalemic activities of Hydrochlorothiazide.
Riociguat
Hydrochlorothiazide may increase the hypotensive activities of Riociguat.
Risperidone
Hydrochlorothiazide may increase the hypotensive activities of Risperidone.
Ritodrine
Ritodrine may increase the hypokalemic activities of Hydrochlorothiazide.
Rituximab
Hydrochlorothiazide may increase the hypotensive activities of Rituximab.
Rofecoxib
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Rofecoxib.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydrochlorothiazide.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Hydrochlorothiazide.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Hydrochlorothiazide.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Hydrochlorothiazide.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Hydrochlorothiazide.
Salicylamide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Salicylamide.
Salicylic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Salicylic acid.
Salmeterol
Salmeterol may increase the hypokalemic activities of Hydrochlorothiazide.
Salsalate
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Salsalate.
Saxagliptin
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Hydrochlorothiazide.
Saxagliptin Anhydrous
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Hydrochlorothiazide.
Scopolamine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Scopolamine.
Scopolamine Hydrobromide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Scopolamine.
Secobarbital
Secobarbital may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Selegiline
Selegiline may increase the hypotensive activities of Hydrochlorothiazide.
Selexipag
Hydrochlorothiazide may increase the hypotensive activities of Selexipag.
Serratiopeptidase
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Serrapeptase.
Sertraline
Sertraline may increase the hyponatremic activities of Hydrochlorothiazide.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Hydrochlorothiazide.
Sildenafil
Sildenafil may increase the antihypertensive activities of Hydrochlorothiazide.
Sitagliptin
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Hydrochlorothiazide.
Sitagliptin Phosphate
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Hydrochlorothiazide.
Sodium Phosphate
Hydrochlorothiazide may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Hydrochlorothiazide may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Hydrochlorothiazide may increase the nephrotoxic activities of Sodium phosphate.
Solifenacin
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Solifenacin.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Hydrochlorothiazide.
Spirapril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Hydrochlorothiazide.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Hydrochlorothiazide.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Hydrochlorothiazide.
Sulfasalazine
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Sulfasalazine.
Sulpiride
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Sulpiride.
Suprofen
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Suprofen.
Tacalcitol
The risk or severity of hyperkalemia can be increased when Tacalcitol is combined with Hydrochlorothiazide.
Tadalafil
Tadalafil may increase the antihypertensive activities of Hydrochlorothiazide.
Talinolol
Hydrochlorothiazide may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Hydrochlorothiazide.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Hydrochlorothiazide.
Telmisartan
Telmisartan may increase the hypotensive activities of Hydrochlorothiazide.
Tenoxicam
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tenoxicam.
Terazosin
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Terazosin.
Terbutaline
Terbutaline may increase the hypokalemic activities of Hydrochlorothiazide.
Terbutaline Sulfate
Terbutaline may increase the hypokalemic activities of Hydrochlorothiazide.
Teriflunomide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Teriflunomide.
Terlipressin
Hydrochlorothiazide may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Hydrochlorothiazide.
Theodrenaline
Hydrochlorothiazide may increase the hypotensive activities of Theodrenaline.
Thiamylal
Thiamylal may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Thiopental
Thiopental may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Thiopental Sodium
Thiopental may increase the orthostatic hypotensive activities of Hydrochlorothiazide.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Hydrochlorothiazide.
Tiaprofenic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tiaprofenic acid.
Tibolone
Hydrochlorothiazide may increase the hypotensive activities of Tibolone.
Timolol
Timolol may increase the hypotensive activities of Hydrochlorothiazide.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Hydrochlorothiazide.
Tiotropium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Tiotropium.
Tixocortol
Tixocortol may increase the hypokalemic activities of Hydrochlorothiazide.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Hydrochlorothiazide.
Tolazamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydrochlorothiazide.
Tolazoline
Tolazoline may increase the hypotensive activities of Hydrochlorothiazide.
Tolbutamide
The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Hydrochlorothiazide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Hydrochlorothiazide.
Tolfenamic Acid
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tolfenamic Acid.
Tolmetin
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tolmetin.
Toloxatone
Toloxatone may increase the hypotensive activities of Hydrochlorothiazide.
Tolterodine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Tolterodine.
Topiramate
Hydrochlorothiazide may increase the hypokalemic activities of Topiramate.
Toremifene
Hydrochlorothiazide may increase the hypercalcemic activities of Toremifene.
Torsemide
Torasemide may increase the hypotensive activities of Hydrochlorothiazide.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Hydrochlorothiazide.
Trandolapril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Trandolapril.
Tranilast
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tranilast.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Hydrochlorothiazide.
Travoprost
Travoprost may increase the hypotensive activities of Hydrochlorothiazide.
Treprostinil
Treprostinil may increase the hypotensive activities of Hydrochlorothiazide.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydrochlorothiazide.
Triamcinolone
Triamcinolone may increase the hypokalemic activities of Hydrochlorothiazide.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Hydrochlorothiazide.
Tricalcium Phosphate
Hydrochlorothiazide may decrease the excretion rate of Calcium Phosphate which could result in a higher serum level.
Trichlormethiazide
Hydrochlorothiazide may increase the hypotensive activities of Trichlormethiazide.
Trihexyphenidyl
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Trihexyphenidyl.
Trihexyphenidyl Hydrochloride
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Trihexyphenidyl.
Trimethaphan
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Trimethaphan.
Troglitazone
The therapeutic efficacy of Troglitazone can be decreased when used in combination with Hydrochlorothiazide.
Tropicamide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Tropicamide.
Trospium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Trospium.
Tubocurarine
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Tubocurarine.
Umeclidinium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Umeclidinium.
UNOPROSTONE
Hydrochlorothiazide may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Hydrochlorothiazide.
Valdecoxib
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Valdecoxib.
Valsartan
Hydrochlorothiazide may increase the hypotensive activities of Valsartan.
Vardenafil
Vardenafil may increase the antihypertensive activities of Hydrochlorothiazide.
Vecuronium
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Vecuronium.
Venlafaxine
Venlafaxine may increase the hyponatremic activities of Hydrochlorothiazide.
Verapamil
The risk or severity of adverse effects can be increased when Verapamil is combined with Hydrochlorothiazide.
Vilanterol
Vilanterol may increase the hypokalemic activities of Hydrochlorothiazide.
Vildagliptin
The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Hydrochlorothiazide.
Vincamine
Hydrochlorothiazide may increase the hypotensive activities of Vincamine.
Vinpocetine
Hydrochlorothiazide may increase the hypotensive activities of Vinpocetine.
Vitamin D
The risk or severity of hyperkalemia can be increased when Vitamin D is combined with Hydrochlorothiazide.
Xylometazoline
Hydrochlorothiazide may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Hydrochlorothiazide.
Zileuton
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Zileuton.
Zofenopril
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Zofenopril.
Zomepirac
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Zomepirac.
